Workflow
Sonoco(SON)
icon
Search documents
TOPPAN Holdings Acquires Sonoco's TFP Business
Prnewswire· 2024-12-19 02:21
Agreement reached on acquisition of Sonoco's TFP business as TOPPAN Group accelerates expansion of sustainable packaging business in AmericasTOKYO, Dec. 18, 2024 /PRNewswire/ -- TOPPAN Holdings Inc. (TYO: 7911) (TOPPAN Holdings) has entered into an agreement with Sonoco Products Company (NYSE: SON) (Sonoco), a global leader in high-value sustainable packaging, to acquire Sonoco's Thermoformed & Flexible Packaging (TFP) business for approximately $1.8 billion on a cash-free and debt-free basis and subject to ...
Sonoco Completes Strategic Review, Announces Agreement to Sell Thermoformed and Flexibles Packaging (TFP) Business to TOPPAN Holdings Inc.
GlobeNewswire· 2024-12-18 22:00
HARTSVILLE, S.C., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today announced it has entered into an agreement to sell its Thermoformed and Flexibles Packaging business (“TFP”) to TOPPAN Holdings Inc. (“Toppan”) for approximately $1.8 billion on a cash-free and debt-free basis and subject to customary adjustments (the “Transaction”). The Transaction, which reflects the completion of the previously ann ...
Sonoco Completes Strategic Review, Announces Agreement to Sell Thermoformed and Flexibles Packaging (TFP) Business to TOPPAN Holdings Inc.
Newsfilter· 2024-12-18 22:00
HARTSVILLE, S.C., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company ("Sonoco" or the "Company") (NYSE:SON), a global leader in high-value sustainable packaging, today announced it has entered into an agreement to sell its Thermoformed and Flexibles Packaging business ("TFP") to TOPPAN Holdings Inc. ("Toppan") for approximately $1.8 billion on a cash-free and debt-free basis and subject to customary adjustments (the "Transaction"). The Transaction, which reflects the completion of the previously anno ...
Sonnet BioTherapeutics Announces Publication Detailing the Discovery and Development of SON-1010, an Albumin-Binding IL-12 Fusion Protein, Demonstrating Its Mechanism of Action
GlobeNewswire News Room· 2024-12-04 14:20
Pankaj Mohan, CEO of Sonnet discusses what this publication means in a Virtual Investor “What This Means” segment; access here PRINCETON, NJ, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted immunotherapeutic drugs, today announced the publication of extensive discovery, development and preclinical data on SON-1010 demonstrating its mechanism of action in Frontiers in Immunology. SON-10 ...
Sonoco Products: M&A Activity Should Support Shares In 2025 (Rating Upgrade)
Seeking Alpha· 2024-12-04 11:06
Shares of Sonoco Products (NYSE: SON ) have been a poor performer over the past year, missing out on the equity rally as they declined by 8%. I last covered shares in May , downgrading them to a “hold” from “buy.” While IOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a question for an article, just let me know!Analyst’s Disclo ...
Sonoco Completes Acquisition of Eviosys
GlobeNewswire News Room· 2024-12-04 09:00
Creates a Global Leader in Metal Food and Aerosol Can Manufacturing Advances Sonoco’s Portfolio Transformation Strategy HARTSVILLE, S.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today announced the close of its acquisition of Eviosys, Europe’s leading food cans, ends and closures manufacturer, from KPS Capital Partners, LP (“KPS”). The transaction advances Sonoco’s portfolio transformation strate ...
Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
GlobeNewswire News Room· 2024-11-12 14:15
Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S. patent covering a variant of IL-18 incorporated into two novel immunotherapeutic drug candidates, SON-1400 and SON-1411 Watch the “What this Means” segment here PRINCETON, NJ, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted immunotherapeutic drugs, today announced that Pankaj ...
Sonoco Earnings Surpass Estimates in Q3, Sales Decrease 2% Y/Y
ZACKS· 2024-11-04 18:30
Sonoco Products Company (SON) reported adjusted earnings per share (EPS) of $1.49 in third-quarter 2024, beating the Zacks Consensus Estimate of $1.44. The figure was within the company’s guidance of $1.40-$1.60. The bottom line improved 2% from the prior-year quarter.Including one-time items, the company reported an EPS of 51 cents compared with the year-ago quarter’s $1.32.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Sonoco’s net sales were $1.68 billion, which missed the Zacks C ...
Sonoco(SON) - 2024 Q3 - Earnings Call Transcript
2024-11-01 22:37
Sonoco Products Company (NYSE:SON) Q3 2024 Earnings Call Transcript November 1, 2024 8:30 AM ET Company Participants Lisa Weeks - VP of IR Howard Coker - President and CEO Rob Dillard - CFO Rodger Fuller - COO Conference Call Participants George Staphos - Bank of America Securities Ghansham Panjabi - Baird Matt Roberts - Raymond James Anthony Pettinari - Citi Mark Weintraub - Seaport Research Partners Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. My name is Krista, and I ...
Sonoco(SON) - 2024 Q3 - Earnings Call Presentation
2024-11-01 14:56
3RD QUARTER 2024 EARNINGS RESULTS November 1, 2024 FORWARD-LOOKING STATEMENTS / NON-GAAP FINANCIAL MEASURES 2 Statements included herein that are not historical in nature, are intended to be, and are hereby identified as "forward-looking statements" for purposes of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. In addition, theCompany and its representatives may from time to time make other oral or written statements that are also "forward-looking statements." Wo ...